REGNON

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.

NamnREGNON

RankNo.3704

Marknadsvärde$0.00

Marknadsvärde efter full utspädning$0.00

Marknadsandel%

Handelsvolym/marknadsvärde (24h)126,909,521.10%

Cirkulationsutbud0.57668589

Maxutbud0

Totalt utbud0.57668589

Cirkulationshastighet%

Utgivningsdatum--

Det pris till vilket tillgången först emitterades--

Högsta någonsin778.9210127183559,2026-04-02

Lägsta pris671.4998645317189,2026-04-30

Offentlig blockkedjaETH

IntroduktionRegeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion.

Sektor

Sociala medier

• Officiell webbplats
• Blockutforskare

etfindex:mc_etfindex_sourceAnsvarsfriskrivning: Data tillhandahålls av cmc och ska inte betraktas som investeringsrådgivning.